Dr. James Mansel Harris, MD

Dr. Harris practices at Confluence Health Hospital | Central Campus in Wenatchee, Washington, part of Confluence Health.

Dr. Harris' NPI, 1780614289, was assigned on July 3, 2006. Dr. Harris holds Washington license MD61469406.

Dr. Harris' primary practice is Confluence Health Hospital | Central Campus, at 1201 S Miller Street, Wenatchee, WA 98807 in Chelan County. The practice phone is (509) 662-1511.

Dr. Harris' primary practice is Confluence Health Hospital | Central Campus in Wenatchee, Washington, part of Confluence Health. Dr. Harris is also affiliated with Mid Valley Hospital. The medical group on file is Confluence Health. Dmand AI also links Dr. Harris to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harris practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Harris' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Harris is licensed in Washington.

CMS data shows 653 Medicare services from Dr. Harris across 14 procedure codes in 2024, for 425 Medicare patients. Medicare paid $50,670 for them.

CMS counts 425 Medicare patients who saw Dr. Harris in 2024. The largest group is 65 to 74, with 184 patients. 70% of them have high blood pressure, and 61% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harris' median patient age at 67, with 30% women.

In 2024, Dr. Harris wrote 732 Medicare Part D claims for 327 patients. 92% of them were for generic drugs. CMS names the drug for 597 of them, across 16 drugs with 11 or more claims each, at $43,955 in total drug cost. In 2023, CMS named 1,887 claims across 28 drugs.

Dr. Harris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harris as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Harris, more than 67% of the clinicians it reports for that procedure.

CMS Open Payments shows 12 general payments to Dr. Harris from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Sanofi and Genzyme US Companies paid the most, $123.